Cordis Corporation Sustainability Profile
Cordis Corporation, a leading player in the medical device industry, is headquartered in the United States. Founded in 1959, the company has established itself as a pioneer in cardiovascular and endovascular solutions, focusing on innovative products that enhance patient outcomes. With a strong presence in North America, Europe, and Asia, Cordis is renowned for its advanced catheter and stent technologies. The company’s core offerings include a range of vascular access devices and interventional solutions, distinguished by their quality and efficacy. Cordis has achieved significant milestones, including the development of groundbreaking products that have set industry standards. As a trusted name in healthcare, Cordis Corporation continues to strengthen its market position through a commitment to innovation and excellence in patient care.
DitchCarbon Score
How does Cordis Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cordis Corporation's score of 70 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
In 2024, Cordis Corporation reported total emissions of approximately 12,000,020 kg CO2e, comprising 1,545,350 kg CO2e from Scope 1 and 10,754,670 kg CO2e from Scope 2 emissions. Notably, there is no reported data for Scope 3 emissions. As a current subsidiary of Cardinal Health, Inc., Cordis Corporation's climate commitments and reduction initiatives are influenced by its parent company's sustainability strategies. However, specific reduction targets or achievements have not been disclosed for Cordis. The absence of documented reduction targets suggests a need for further development in their climate action plans. Cordis Corporation's emissions data reflects its operational impact, and as part of the healthcare industry, it is essential for the company to align with broader climate goals and initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2009 | 2010 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 148,856,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 212,644,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is Cordis Corporation's Industry?
How Carbon Intensive is Cordis Corporation's Location?
Cordis Corporation's Scope 3 Categories Breakdown
Cordis Corporation's Scope 3 emissions, which increased by 5% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 93% of Scope 3 emissions.
Top Scope 3 Categories
Cordis Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cordis Corporation has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Abbott
AngioDynamics, Inc.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.